IceCure Medical Ltd (ICCM)
USD 1.14
(-7.67%)
USD 1.14
(-7.67%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 376 Thousand USD | -12.56% |
| 2022 | 430 Thousand USD | -37.23% |
| 2021 | 685 Thousand USD | 683.87% |
| 2020 | 87.38 Thousand ILS | -20.99% |
| 2019 | 110.6 Thousand ILS | 0.0% |
| 2018 | - ILS | 0.0% |
| 2017 | - ILS | 0.0% |
| 2016 | - ILS | 0.0% |
| 2015 | - ILS | 0.0% |
| 2014 | - ILS | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 269 Thousand USD | 0.0% |
| 2024 Q1 | 312 Thousand USD | 0.0% |
| 2023 Q4 | 376 Thousand USD | -0.79% |
| 2023 FY | 376 Thousand USD | -12.56% |
| 2023 Q2 | 399 Thousand USD | 6.12% |
| 2023 Q1 | 376 Thousand USD | -12.56% |
| 2023 Q3 | 379 Thousand USD | -5.01% |
| 2022 Q1 | 617 Thousand USD | -9.93% |
| 2022 FY | 430 Thousand USD | -37.23% |
| 2022 Q3 | 476 Thousand USD | -12.18% |
| 2022 Q4 | 430 Thousand USD | -9.66% |
| 2022 Q2 | 542 Thousand USD | -12.16% |
| 2021 FY | 685 Thousand USD | 683.87% |
| 2021 Q3 | 2.63 Million USD | 778.13% |
| 2021 Q4 | 685 Thousand USD | -73.99% |
| 2021 Q2 | 299.96 Thousand USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q3 | - USD | -100.0% |
| 2020 Q4 | 87.38 Thousand ILS | 0.0% |
| 2020 FY | 87.38 Thousand ILS | -20.99% |
| 2020 Q1 | 526.26 Thousand USD | 375.81% |
| 2020 Q2 | 152.58 Thousand ILS | -71.01% |
| 2019 Q4 | 110.6 Thousand ILS | -71.12% |
| 2019 FY | 110.6 Thousand ILS | 0.0% |
| 2019 Q1 | 616 Thousand USD | 0.0% |
| 2019 Q2 | 172.36 Thousand ILS | -72.02% |
| 2019 Q3 | 383 Thousand USD | 122.21% |
| 2018 Q4 | - ILS | 0.0% |
| 2018 Q2 | - ILS | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - ILS | 0.0% |
| 2017 FY | - ILS | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | - ILS | 0.0% |
| 2017 Q2 | - ILS | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | - ILS | 0.0% |
| 2016 FY | - ILS | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 FY | - ILS | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 FY | - ILS | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 98.959% |
| BrainsWay Ltd. | 239 Thousand USD | -57.322% |
| Cerus Corporation | 59.79 Million USD | 99.371% |
| Envoy Medical, Inc. | 404 Thousand USD | 6.931% |
| electroCore, Inc. | 537 Thousand USD | 29.981% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -3033.333% |
| Inogen, Inc. | 18.27 Million USD | 97.942% |
| OrthoPediatrics Corp. | 13.45 Million USD | 97.206% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -88.945% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -3.375% |
| MaxCyte, Inc. | 17.96 Million USD | 97.908% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -580.124% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 99.596% |
| PAVmed Inc | 2.96 Million USD | 87.297% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 93.949% |
| RxSight, Inc. | 1.21 Million USD | 68.951% |
| Sight Sciences, Inc. | 31.7 Million USD | 98.814% |
| SI-BONE, Inc. | 36.06 Million USD | 98.957% |
| TELA Bio, Inc. | 40.51 Million USD | 99.072% |
| Treace Medical Concepts, Inc. | 53 Million USD | 99.291% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | 75.279% |
| Acutus Medical, Inc. | 32.65 Million USD | 98.849% |
| Talis Biomedical Corporation | 16.78 Million USD | 97.76% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 90.705% |
| CVRx, Inc. | 30.38 Million USD | 98.762% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | 63.026% |
| Bioventus Inc. | 366.99 Million USD | 99.898% |
| Venus Concept Inc. | 70.79 Million USD | 99.469% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | 69.775% |
| LivaNova PLC | 568.54 Million USD | 99.934% |
| 908 Devices Inc. | 3.92 Million USD | 90.43% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.926% |
| Nemaura Medical Inc. | 3.08 Million USD | 87.822% |
| NeuroPace, Inc. | 56.95 Million USD | 99.34% |
| LENSAR, Inc. | 1.75 Million USD | 78.514% |
| Apyx Medical Corporation | 33.18 Million USD | 98.867% |
| Cutera, Inc. | 418.69 Million USD | 99.91% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 97.501% |
| BioSig Technologies, Inc. | 103 Thousand USD | -265.049% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 98.602% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 96.221% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.975% |
| Axonics, Inc. | 25.84 Million USD | 98.545% |
| Outset Medical, Inc. | 134.59 Million USD | 99.721% |
| IRIDEX Corporation | 1.75 Million USD | 78.527% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 99.268% |
| IRadimed Corporation | 1.61 Million USD | 76.719% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -113.636% |
| INVO Bioscience, Inc. | 6.77 Million USD | 94.451% |
| Telesis Bio, Inc. | 5.26 Million USD | 92.864% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 93.703% |
| Varex Imaging Corporation | 464.2 Million USD | 99.919% |
| Quipt Home Medical Corp. | 60.82 Million USD | 99.382% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 36.054% |
| Pulmonx Corporation | 35.08 Million USD | 98.928% |
| Dynatronics Corporation | 3.25 Million USD | 88.461% |
| Modular Medical, Inc. | 817 Thousand USD | 53.978% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -149.007% |
| Semler Scientific, Inc. | 70 Thousand USD | -437.143% |
| InMode Ltd. | 6.61 Million USD | 94.314% |
| Bruker Corporation | 1.14 Billion USD | 99.967% |
| Cytosorbents Corporation | 2.54 Million USD | 85.213% |
| DexCom, Inc. | 2.57 Billion USD | 99.985% |
| Align Technology, Inc. | 96.96 Million USD | 99.612% |
| Viveve Medical, Inc. | 5.12 Million USD | 92.662% |
| ZimVie Inc. | 508.79 Million USD | 99.926% |
| Movano Inc. | 15.00 USD | -2506566.667% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 97.926% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.906% |
| Profound Medical Corp. | 4.97 Million USD | 92.441% |
| Insulet Corporation | 1.36 Billion USD | 99.972% |
| enVVeno Medical Corporation | 1.06 Million USD | 64.662% |
| Surmodics, Inc. | 29.4 Million USD | 98.721% |
| iCAD, Inc. | 273 Thousand USD | -37.729% |
| Nuwellis, Inc. | 221 Thousand USD | -70.136% |
| Biotricity, Inc. | 10.85 Million USD | 96.536% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 98.924% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | 42.132% |
| InspireMD, Inc. | 1.03 Million USD | 63.776% |
| PAVmed Inc. | 2.96 Million USD | 87.297% |
| BIOLASE, Inc. | 13.98 Million USD | 97.311% |
| Beyond Air, Inc. | 14.72 Million USD | 97.446% |
| FONAR Corporation | 37.92 Million USD | 99.009% |
| AxoGen, Inc. | 46.6 Million USD | 99.193% |
| Vivani Medical, Inc. | 19.31 Million USD | 98.053% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 99.157% |
| Inari Medical, Inc. | 30.35 Million USD | 98.761% |
| UFP Technologies, Inc. | 28 Million USD | 98.657% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | 13.373% |
| Tenon Medical, Inc. | 428 Thousand USD | 12.15% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | 62.475% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 82.529% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.982% |
| Sintx Technologies, Inc. | 3.68 Million USD | 89.802% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 98.99% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | 36.054% |
| Sensus Healthcare, Inc. | 596 Thousand USD | 36.913% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.958% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.926% |
| ReWalk Robotics Ltd. | 607 Thousand USD | 38.056% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -306.552% |
| Hyperfine, Inc. | 64 Thousand USD | -487.5% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.801% |
| Biomerica, Inc. | 459 Thousand USD | 18.083% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | 16.348% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -97.908% |
| Silk Road Medical, Inc | 75.62 Million USD | 99.503% |